Astoria Portfolio Advisors Llc. Astrazeneca PLC Transaction History
Astoria Portfolio Advisors Llc.
- $284 Million
- Q3 2025
A detailed history of Astoria Portfolio Advisors Llc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Astoria Portfolio Advisors Llc. holds 4,339 shares of AZN stock, worth $387,906. This represents 0.12% of its overall portfolio holdings.
Number of Shares
4,339
Previous 4,338
0.02%
Holding current value
$387,906
Previous $303,000
9.57%
% of portfolio
0.12%
Previous 0.11%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,541Shares Held
503MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...